BRIEF RESEARCH REPORT
Published on 04 Apr 2025
A selective C5a-derived peptidomimetic enhances IgG response following inactivated SARS-CoV-2 immunization and confers rapid disease resolution following murine coronavirus infection
doi 10.3389/fimmu.2025.1470034
- 478 views